Cannabis use in smokers with IBS was linked to anxiety
Relationships Between Risky Substance Use and Irritable Bowel Syndrome (IBS) Severity, Mental Health, and Smoking-Related Processes in Adults with IBS Who Smoke.
AI Summary
This cross-sectional study examined 263 adults who met Rome IV criteria for irritable bowel syndrome (IBS) and smoked combustible cigarettes. Researchers assessed whether risky use of alcohol, cannabis, or opioids was related to IBS symptom severity, quality of life, anxiety, depression, and smoking-related factors. The abstract does not report effect sizes or percentages.
Risky cannabis use was significantly associated only with anxiety symptoms in this study. By comparison, risky alcohol use was associated with anxiety and depression, while opioid use was statistically related to all the outcomes examined. Because the study was cross-sectional, these findings show relationships rather than proving that cannabis or other substances caused changes in IBS or mental health. The authors conclude that substance-use screening and intervention may help improve care for people with IBS who smoke, beyond medical treatment alone.
π‘ Key Findings
π
Original Abstract
Related Research
Similar Studies
More Anxiety research papers you might find interesting.
Review finds strongest evidence in select seizure and MS symptoms
CBD prevented stress-related fear-extinction deficits in male rats
Mouse study links CBDβs anxiety-like effects to LHb Ξ±3 glycine receptors
Explore More Research
Stay informed about the latest cannabis science.